SPOTLIGHT -
Chester M. Pierce Human Rights Award Winner to Give Inaugural Award Lecture at 2022 APA Annual Meeting
This year’s winner is a pioneer for the human rights of individuals with mental illness in West Africa.
Study Examines Relationship Between Methylphenidate and Risk of Depression
Investigators observed higher levels of depression in children and adolescents with ADHD during MPH treatment.
Study Examines Best Practices for Managing Perinatal Depression
Recommendations are often vague, contradictory, according to investigators.
Study Explores Link Between ADHD and Internet Gaming Disorder
Some of the more severe ADHD symptoms noted were depression/withdrawal, problems with socialization.
Phase 3 Study on Treatment of Agitation in Alzheimer Disease Doses First Patient
Top-line data for study is expected in late 2022, early 2023.
Study Shows 2 in 5 Adults with ADHD are in Exceptional Mental Health
Physical activity, marital status among factors contributing to complete mental health among participants.
FDA Approves Novel Nonstimulant for Treatment of ADHD in Adults
Approval comes 1 year after the drug was approved for the treatment of ADHD in children and adolescents.
Support Gathers for Biden Administration’s 2022 National Drug Control Strategy
Strategy highlights plans of action to address untreated addiction, overdose epidemic.
Individuals Cite Exercise, Gaming as Top Ways to Address Mental Health Issues
The most common issues during the COVID-19 pandemic included stress, anxiety.
APhA Conference Addresses Depression, Benzos
Catch up on all the latest from the American Pharmacists Association (APhA) Annual Meeting & Exposition.
FDA Sends Warning to Websites Over Illegal Sale of Adderall
The warnings cite consumer risks, as well as FD&C, RHA violations.
Study Identifies Urgent Need for More Research on Pain in Severe Mental Illness
Evidence review focuses on bipolar disorder, psychosis, and major depression.
In Case You Missed It: Medical World News Season 5
In Season 5, the psychiatric community weighed in on everything from finding meaning in music to the importance of mindfulness.
Research Explores Neurocognitive Profile, Cognitive Impairment in MDD
Study supports evidence for long-term impairment in memory, executive function.
Celebrating Women Who Inspire
In honor of Women's History Month, our contributors celebrate the women who inspire them.
Study Assesses Current Research on Blue Light Blocking Treatment for Bipolar Disorder
Although research is limited, the results are promising.
Study Links Lithium With Lower Risk of Dementia
Research also finds surprising results in patients with bipolar affective disorder.
Research Roundup: Psychiatric Comorbidities in the News
Catch up on all the latest in psychiatric comorbidities.
Study Shows Risk Awareness of Concurrent Benzodiazepine, Opioid Use Among Patients
Results highlight the impact of education on patient understanding of potential adverse events.
Seeing Things: Mind or Brain?
Researchers explore the psychiatric and neurological etiologies of visual hallucinations.
Study Shows Effects of Antidepressant Use on Lipid Biomarkers
Results are clinically significant for the treatment of patients with major depressive disorder.
Research Identifies Key Differences Between LSD and Psilocybin
Drug comparison has significant implications for dose- and substance-dependence.
Study Connects Key Neural Mechanism to Bulimia Nervosa
Findings show relationship between binge eating and brain activation.
In Case You Missed It: February 2022
Psychiatric Times featured a wide variety of psychiatric issues and current events throughout February.
From the Pages of Psychiatric Times: February 2022
The experts weighed in on a wide variety of psychiatric issues for the Psychiatric Times February 2022 issue.
Older Adults’ Attitudes on Mental Health Care
Respondents discussed COVID-19 conditions and mental health benefits.
Researchers Address Youth Suicide Prevention in Virtual Panel
Panelists presented 2 studies comparing evidence-based strategies for improved patient outcomes.
New sNDA Submitted to FDA for Major Depressive Disorder
If approved, this will be the fourth indication for the drug, joining its approvals for episodes associated with bipolar I disorder and schizophrenia.
Spotlight on Issues in ADHD
Catch up on all the latest in ADHD from the APSARD virtual 2022 Annual Meeting.
Medical Comorbidities May Increase COVID-19 Mortality Risk in Patients with Psychiatric Disorders
Obesity, antidepressants may also impact risk of death in this population.